X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. AUROBINDO PHARMA FDC LTD./
AUROBINDO PHARMA
 
P/E (TTM) x 24.0 15.6 153.5% View Chart
P/BV x 5.0 4.0 124.6% View Chart
Dividend Yield % 0.9 0.4 243.3%  

Financials

 FDC LTD.   AUROBINDO PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
AUROBINDO PHARMA
Mar-17
FDC LTD./
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs144895 16.0%   
Low Rs79622 12.7%   
Sales per share (Unadj.) Rs47.6254.6 18.7%  
Earnings per share (Unadj.) Rs7.639.3 19.4%  
Cash flow per share (Unadj.) Rs9.046.6 19.3%  
Dividends per share (Unadj.) Rs2.252.50 90.0%  
Dividend yield (eoy) %2.00.3 613.6%  
Book value per share (Unadj.) Rs47.5160.0 29.7%  
Shares outstanding (eoy) m177.83585.88 30.4%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x2.33.0 78.5%   
Avg P/E ratio x14.619.3 75.7%  
P/CF ratio (eoy) x12.316.3 75.8%  
Price / Book Value ratio x2.34.7 49.4%  
Dividend payout %29.66.4 464.6%   
Avg Mkt Cap Rs m19,784444,390 4.5%   
No. of employees `000NA14.0 0.0%   
Total wages/salary Rs m1,22117,678 6.9%   
Avg. sales/employee Rs ThNM10,667.8-  
Avg. wages/employee Rs ThNM1,264.3-  
Avg. net profit/employee Rs ThNM1,645.8-  
INCOME DATA
Net Sales Rs m8,459149,157 5.7%  
Other income Rs m3941,159 34.0%   
Total revenues Rs m8,852150,316 5.9%   
Gross profit Rs m2,07034,343 6.0%  
Depreciation Rs m2494,276 5.8%   
Interest Rs m31667 4.6%   
Profit before tax Rs m2,18430,558 7.1%   
Minority Interest Rs m050 0.0%   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6067,597 8.0%   
Profit after tax Rs m1,35323,012 5.9%  
Gross profit margin %24.523.0 106.3%  
Effective tax rate %27.724.9 111.6%   
Net profit margin %16.015.4 103.7%  
BALANCE SHEET DATA
Current assets Rs m4,35592,062 4.7%   
Current liabilities Rs m1,79266,223 2.7%   
Net working cap to sales %30.317.3 174.9%  
Current ratio x2.41.4 174.8%  
Inventory Days Days44106 41.9%  
Debtors Days Days2568 36.4%  
Net fixed assets Rs m3,02562,919 4.8%   
Share capital Rs m179586 30.5%   
"Free" reserves Rs m8,24393,133 8.9%   
Net worth Rs m8,45393,719 9.0%   
Long term debt Rs m111,814 0.6%   
Total assets Rs m10,557162,494 6.5%  
Interest coverage x71.446.8 152.6%   
Debt to equity ratio x00 6.5%  
Sales to assets ratio x0.80.9 87.3%   
Return on assets %13.114.6 90.0%  
Return on equity %16.024.6 65.2%  
Return on capital %23.532.7 71.8%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,14675,838 1.5%   
Fx outflow Rs m35530,224 1.2%   
Net fx Rs m79145,613 1.7%   
CASH FLOW
From Operations Rs m1,48532,786 4.5%  
From Investments Rs m-620-17,870 3.5%  
From Financial Activity Rs m-753-19,153 3.9%  
Net Cashflow Rs m113-4,239 -2.7%  

Share Holding

Indian Promoters % 68.9 54.1 127.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 8.0 59.1%  
FIIs % 7.5 27.7 27.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 10.2 186.3%  
Shareholders   23,730 69,601 34.1%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   IPCA LABS  SANOFI INDIA  ALEMBIC PHARMA  MERCK LTD  NOVARTIS  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jan 19, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS